All News

Axicabtagene ciloleucel (Yescarta) received accelerated FDA approval on March 5, 2021, for the treatment of adult patients with relapsed or refractory FL after 2 or more lines of systemic therapy.

This week on Pharmacy Times, there are a number of important topics that will be covered and posted throughout the week.

Ten quiz questions to assess your knowledge on common diabetes treatments.

Aldosterone blockers, such as spironolactone and eplerenone, can cause hyperkalemia.

Follow these 6 tips for making the move to a nontraditional career or role within the profession.

How would you respond to these patients' concerns?

Ken Perez, MBA, vice president of healthcare policy and government affairs at Omnicell, discussed the changes that would take place if pharmacists were granted provider status for Medicare Part B.

Consider key elements of acute bacterial skin and skin structure infection to help patients manage this broad range of diseases.

A new survey conducted by The Harris Poll on behalf of the Samueli Foundation found that 29% of Americans are taking more supplements compared with before the COVID-19 pandemic, bringing the nationwide percentage of supplement-takers to 76%.

The findings showed that on average, college students with ADHD received grades that were half a grade level below their peers in all 4 years.

The FDA has granted Orphan Drug Designation (ODD) to alrizomadlin (APG-115, Ascentage Pharma) for the treatment of stage IIB-IV melanoma.

Cawkwell and his colleagues emphasized the need for further research to clarify the possible effects of cannabis on brain structure, function, and behavior in young people with ADHD.

Investigators have found that a small percentage of epidermal growth factor receptor (EGFR) inhibitor-resistant cancer cells are present in certain patients with non-small cell lung cancers (NSCLCs), potentially explaining tumor regrowth in these patients.

Because there are no other available treatment options, Pamela Spicer said the approval of aducanumab gives much-needed hope to patients with Alzheimer disease and their families.

The investigators said the ACA helped lower the financial burden for younger cancer survivors to its lowest estimated levels in 20 years.

Location, class size, student-to-faculty ratio, and a strong alumni network are some of the recommendations that Campbell highlighted as main points to look for in a program.

Staying on track with immunizations means modifying workflows and reallocating pharmacy staff time.

Below a certain GFR, clinically significant reductions in plasma glucose cannot be achieved with sodium-glucose transport protein 2 inhibitors.

Trials assessing psychedelic medicine were conducted in the United States for several decades before they were criminalized in 1968, with government and military funding provided for research in the field.

Understanding the categories is key to evaluating and making decisions about outsourcing products or improving internal production standards.

This recurring condition can require more firepower than OTC pain medications offer.

Uncertainty and preparedness make strange bedfellows.

The FDA has approved pembrolizumab in combination with lenvatinib for the treatment of advanced endometrial carcinoma that is not microsatellite instability-high or mismatch repair deficient

Although she said it is unlikely that the FDA will retract the approval, prescribers could be reluctant to administer aducanumab to patients.

The results indicated that T cell responses—including CD8+ T cells, which seek out and destroy infected cells—persisted over the 8-month timeframe of the study, according to the authors.

During a presentation at the 2021 annual meeting of the American Association of Colleges of Pharmacy, the presenters broke down how best to engage colleges of pharmacy to help in establishing payer-provider relationships.

How should pharmacists manage a patient with diabetes on metformin with GFR below 30?

Because white meat, unprocessed red meat, dairy, starch, fruit, vegetables, and legumes were not associated with the development of IBD, the way that the food is processed may confer this risk of IBD, rather than the food itself.

Pharmacy Times interviewed Dennis O’Neill, president and board member of BIOMEDICAN, on the outlook around the future of biosynthesis therapeutics that use rare cannabinoids to treat a range of health issues, from mental health disorders to diabetes.

Venetoclax is already approved for the treatment of adults with chronic lymphocytic leukemia or small lymphocytic lymphoma, and in some adults with newly diagnosed acute myeloid leukemia.